Cory Kasimov
Stock Analyst at Evercore ISI Group
(0)
# 4407
Out of 5,358 analysts
97
Total ratings
46.67%
Success rate
-10.00%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
XENE Xenon Pharmaceutical... | Initiates Coverage On: Outperform | 55 | 31.64 | 73.83% | 1 | May 14, 2025 | |
MRNA Moderna | Maintains: In-Line | 50 32 | 27.47 | 16.49% | 6 | May 2, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Outperform | 190 185 | 125.42 | 47.5% | 2 | Apr 24, 2025 | |
SMMT Summit Therapeutics | Initiates Coverage On: Outperform | 30 | 20.61 | 45.56% | 1 | Mar 12, 2025 | |
SWTX SpringWorks Therapeu... | Maintains: Outperform | 60 65 | 46.8 | 38.89% | 2 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 38.61 | 29.5% | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 15.24 | 228.08% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 110 125 | 108.54 | 15.16% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 115 105 | 56.67 | 85.28% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1250 1175 | 493.12 | 138.28% | 5 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 85 | 68.15 | 24.72% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 37.17 | 136.75% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 250 | n/a | n/a | 2 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | n/a | n/a | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 324 276 | 133.16 | 107.27% | 3 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 2.84 | 1132.39% | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1520 780 | 4.97 | 15594.16% | 3 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 232 | 290.34 | -20.09% | 5 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 163 | n/a | n/a | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | 31.72 | -33.8% | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 83 23 | 3.71 | 519.95% | 6 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 71 16 | n/a | n/a | 8 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 63 | n/a | n/a | 5 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 110 | n/a | n/a | 2 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 15 10 | 0.76 | 1215.79% | 1 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 310 250 | 10.24 | 2341.41% | 1 | Feb 14, 2018 |